China Cord Blood Basic EPS 2010-2022 | CORBF
China Cord Blood basic eps from 2010 to 2022. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| China Cord Blood Annual Basic EPS | |
|---|---|
| 2022 | $0.65 |
| 2021 | $0.64 |
| 2020 | $0.55 |
| 2019 | $0.36 |
| 2018 | $0.33 |
| 2017 | $0.23 |
| 2016 | $0.19 |
| 2015 | $0.22 |
| 2014 | $0.26 |
| 2013 | $0.24 |
| 2012 | $0.28 |
| 2011 | $0.20 |
| 2010 | $0.12 |
| China Cord Blood Quarterly Basic EPS | |
|---|---|
| 2022-03-31 | $0.15 |
| 2021-12-31 | $0.17 |
| 2021-09-30 | $0.16 |
| 2021-06-30 | $0.17 |
| 2021-03-31 | $0.18 |
| 2020-12-31 | $0.15 |
| 2020-09-30 | $0.16 |
| 2020-06-30 | $0.15 |
| 2020-03-31 | $0.11 |
| 2019-12-31 | $0.17 |
| 2019-09-30 | $0.14 |
| 2019-06-30 | $0.13 |
| 2019-03-31 | $0.12 |
| 2018-12-31 | $0.07 |
| 2018-09-30 | $0.08 |
| 2018-06-30 | $0.09 |
| 2018-03-31 | $0.06 |
| 2017-12-31 | $0.09 |
| 2017-09-30 | $0.09 |
| 2017-06-30 | $0.09 |
| 2017-03-31 | $0.07 |
| 2016-12-31 | $0.10 |
| 2016-09-30 | $0.03 |
| 2016-06-30 | $0.03 |
| 2016-03-31 | $0.02 |
| 2015-12-31 | $0.10 |
| 2015-09-30 | $0.04 |
| 2015-06-30 | $0.03 |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | $0.06 |
| 2014-06-30 | $0.06 |
| 2014-03-31 | $0.07 |
| 2013-12-31 | $0.07 |
| 2013-09-30 | $0.05 |
| 2013-06-30 | $0.07 |
| 2013-03-31 | $0.06 |
| 2012-12-31 | $0.07 |
| 2012-09-30 | $0.05 |
| 2012-06-30 | $0.06 |
| 2012-03-31 | $0.06 |
| 2011-12-31 | $0.09 |
| 2011-09-30 | $0.05 |
| 2011-06-30 | $0.08 |
| 2011-03-31 | $0.05 |
| 2010-12-31 | $0.06 |
| 2010-09-30 | $0.05 |
| 2010-06-30 | $0.04 |
| 2010-03-31 | $-0.01 |
| 2009-12-31 | $0.05 |
| 2009-09-30 | $0.04 |
| 2009-06-30 | $0.04 |
| 2009-03-31 | $-0.05 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $0.000B |
| Global Cord Blood Corporation operates as a life sciences company. It provides umbilical cord blood stem cells from newborn babies and offers laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company also operates as cord blood banking operator. Global Cord Blood Corporation, formerly known as China Cord Blood Corporation, is based in Hong Kong, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.067B | 27.09 |
| CVS Health (CVS) | United States | $78.811B | 9.80 |
| Elevance Health (ELV) | United States | $66.101B | 8.89 |
| Cencora (COR) | United States | $56.558B | 19.68 |
| DiDi Global (DIDIY) | China | $24.238B | 25.75 |
| Labcorp Holdings (LH) | United States | $22.089B | 17.43 |
| Natera (NTRA) | United States | $19.248B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.897B | 0.00 |
| ICON (ICLR) | Ireland | $14.657B | 14.10 |
| CochLear (CHEOY) | Australia | $13.278B | 0.00 |
| Solventum (SOLV) | United States | $12.626B | 13.37 |
| Medpace Holdings (MEDP) | United States | $12.299B | 32.55 |
| Revvity (RVTY) | United States | $10.708B | 18.58 |
| Viatris (VTRS) | United States | $10.563B | 3.63 |
| Avantor (AVTR) | United States | $9.404B | 13.66 |
| Sonic Healthcare (SKHHY) | Australia | $8.886B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.654B | 16.96 |
| HealthEquity (HQY) | United States | $8.544B | 37.42 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.505B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $4.851B | 32.64 |
| Amplifon S.p.A (AMFPF) | Italy | $3.871B | 21.19 |
| BrightSpring Health Services (BTSG) | United States | $3.746B | 34.37 |
| Sotera Health (SHC) | United States | $3.382B | 19.22 |
| GeneDx Holdings (WGS) | United States | $2.953B | 68.10 |
| Surgery Partners (SGRY) | United States | $2.867B | 37.28 |
| Concentras Parent (CON) | United States | $2.615B | 15.11 |
| Organon (OGN) | United States | $2.610B | 2.77 |
| Alignment Healthcare (ALHC) | United States | $2.572B | 0.00 |
| Progyny (PGNY) | United States | $2.014B | 44.34 |
| Premier (PINC) | United States | $1.772B | 13.45 |
| GoodRx Holdings (GDRX) | United States | $1.747B | 34.93 |
| PACS (PACS) | United States | $1.710B | 0.00 |
| Ardent Health (ARDT) | United States | $1.528B | 6.51 |
| Teladoc Health (TDOC) | United States | $1.298B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.213B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.065B | 8.10 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.791B | 0.00 |
| CareDx (CDNA) | United States | $0.716B | 11.18 |
| AMN Healthcare Services Inc (AMN) | United States | $0.712B | 6.67 |
| Embecta (EMBC) | United States | $0.611B | 4.11 |
| So-Young (SY) | China | $0.501B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.479B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.471B | 0.00 |
| Nutex Health (NUTX) | United States | $0.467B | 7.06 |
| LifeMD (LFMD) | United States | $0.459B | 0.00 |
| Omada Health (OMDA) | $0.455B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.455B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.454B | 10.23 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.369B | 0.00 |
| Enhabit (EHAB) | United States | $0.338B | 27.83 |
| Oncology Institute (TOI) | United States | $0.329B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.270B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Sera Prognostics (SERA) | United States | $0.108B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.096B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| KindlyMD (NAKA) | United States | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.039B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.017B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.013B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |